VERACYTE, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| McGuire Annie | SVP, General Counsel | Sale | 100 | $43.68 | $4,368 | 67,760 | Dec 16, 2025 |
| EASTHAM KARIN | — | Sale | 6,392 | $44.52 | $284,572 | 27,162 | Dec 5, 2025 |
| McGuire Annie | SVP, General Counsel | Sale | 702 | $47.51 | $33,352 | 78,499 | Dec 4, 2025 |
| Chambers Rebecca | Chief Financial Officer | Tax Withholding | 3,384 | $46.16 | $156,205 | 122,774 | Dec 4, 2025 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Tax Withholding | 2,955 | $46.16 | $136,403 | 89,486 | Dec 2, 2025 |
| Stapley Marc | Chief Executive Officer | Sale | 3,220 | $47.35 | $152,467 | 318,603 | Dec 2, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Sale | 1,278 | $47.51 | $60,718 | 82,113 | Dec 2, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Tax Withholding | 1,325 | $46.16 | $61,162 | 37,420 | Dec 2, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Sale | 2,808 | $50.00 | $140,400 | 86,291 | Nov 25, 2025 |
| JONES EVAN/ FA | — | Sale | 1,106 | $50.25 | $55,577 | 29,362 | Nov 25, 2025 |
| Holstein Jens | — | Sale | 1,460 | $43.21 | $63,087 | 27,199 | Nov 20, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Sale | 5,102 | $42.33 | $215,968 | 38,745 | Nov 7, 2025 |
| McGuire Annie | SVP, General Counsel | Sale | 6,466 | $40.00 | $258,640 | 82,973 | Nov 5, 2025 |
| JONES EVAN/ FA | — | Sale | 408 | $41.74 | $17,030 | 73,256 | Nov 5, 2025 |
| EASTHAM KARIN | — | Sale | 9,674 | $40.02 | $387,153 | 13,554 | Nov 5, 2025 |
| Chambers Rebecca | Chief Financial Officer | Sale | 7,000 | $41.00 | $287,000 | 126,158 | Nov 5, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Award / Grant | 2,886 | — | — | 49,665 | Oct 28, 2025 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Sale | 8,349 | $36.02 | $300,731 | 92,441 | Oct 6, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Sale | 2,539 | $35.00 | $88,865 | 89,099 | Oct 1, 2025 |
| EPSTEIN ROBERT S | — | Sale | 21,473 | $35.08 | $753,273 | 62,446 | Oct 1, 2025 |
| McGuire Annie | SVP, General Counsel | Sale | 2,160 | $35.00 | $75,600 | 89,439 | Oct 1, 2025 |
| McGuire Annie | SVP, General Counsel | Sale | 2,283 | $33.69 | $76,914 | 91,599 | Sep 19, 2025 |
| Stapley Marc | Chief Executive Officer | Sale | 7,667 | $30.41 | $233,153 | 334,185 | Sep 4, 2025 |
| Chambers Rebecca | Chief Financial Officer | Tax Withholding | 5,371 | $30.11 | $161,721 | 133,158 | Sep 2, 2025 |
| McGuire Annie | SVP, General Counsel | Tax Withholding | 3,507 | $30.11 | $105,596 | 93,882 | Sep 2, 2025 |
| Stapley Marc | Chief Executive Officer | Tax Withholding | 7,914 | $30.11 | $238,291 | 341,852 | Sep 2, 2025 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Tax Withholding | 2,955 | $30.11 | $88,975 | 100,790 | Sep 2, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Tax Withholding | 2,902 | $30.11 | $87,379 | 91,638 | Sep 2, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Tax Withholding | 1,648 | $30.11 | $49,621 | 46,779 | Sep 2, 2025 |
| EASTHAM KARIN | — | Award / Grant | 9,321 | — | — | 23,228 | Jun 18, 2025 |
| Holstein Jens | — | Award / Grant | 9,321 | — | — | 37,199 | Jun 18, 2025 |
| JONES EVAN/ FA | — | Award / Grant | 9,321 | — | — | 43,664 | Jun 18, 2025 |
| EPSTEIN ROBERT S | — | Award / Grant | 9,321 | — | — | 73,919 | Jun 18, 2025 |
| Barr Eliav | — | Award / Grant | 9,321 | — | — | 51,189 | Jun 18, 2025 |
| Bhanji Muna | — | Award / Grant | 9,321 | — | — | 39,310 | Jun 18, 2025 |
| Miller Thomas F. | — | Award / Grant | 9,321 | — | — | 25,828 | Jun 18, 2025 |
| Shafer David Brent | — | Award / Grant | 9,321 | — | — | 25,828 | Jun 18, 2025 |
| EASTHAM KARIN | — | Sale | 4,590 | $26.66 | $122,369 | 13,907 | Jun 13, 2025 |
| Bhanji Muna | — | Sale | 4,589 | $26.67 | $122,389 | 29,989 | Jun 13, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Sale | 2,809 | $27.20 | $76,405 | 94,540 | Jun 4, 2025 |
| McGuire Annie | SVP, General Counsel | Tax Withholding | 3,505 | $26.74 | $93,724 | 97,003 | Jun 2, 2025 |
| Chambers Rebecca | Chief Financial Officer | Tax Withholding | 5,370 | $26.74 | $143,594 | 138,529 | Jun 2, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Tax Withholding | 2,900 | $26.74 | $77,546 | 97,349 | Jun 2, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Tax Withholding | 1,848 | $26.74 | $49,416 | 47,915 | Jun 2, 2025 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Tax Withholding | 2,955 | $26.74 | $79,017 | 103,745 | Jun 2, 2025 |
| Stapley Marc | Chief Executive Officer | Tax Withholding | 9,399 | $26.74 | $251,329 | 349,237 | Jun 2, 2025 |
| Leite John | Chief Commercial Officer-CLIA | Award / Grant | 36,240 | — | — | 107,660 | Mar 7, 2025 |
| Wygant Jonathan | VP, Chief Accounting Officer | Award / Grant | 13,288 | — | — | 49,763 | Mar 6, 2025 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Award / Grant | 24,160 | — | — | 106,700 | Mar 6, 2025 |
| Chambers Rebecca | Chief Financial Officer | Award / Grant | 30,200 | — | — | 143,899 | Mar 6, 2025 |